Exploring metabolic candidates and inflammatory mediation in Parkinson's disease: a pilot integrative metabolomics and Mendelian randomization study.
Background Parkinson's disease (PD) is a complex neurodegenerative disorder characterized by multifaceted molecular dysregulation. Integrating genetic approaches with metabolomics may help to systematically investigate potential links between metabolites, inflammatory proteins, and PD risk. Methods In this pilot disc...